SCHEMBL5319072

SCHEMBL5319072

O=C(CN(c1ccc(F)cc1)c1ccc(F)cc1)N(c1ccc(F)cc1)c1ccc(F)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 2/20 0.43
ESR2 Q92731 2/20 0.43
PTPN1 P18031 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
POLB P06746 2/20 0.38
NPC1 O15118 2/20 0.38
RAB9A P51151 2/20 0.38
ALDH1A1 P00352 1/20 0.38
HTT P42858 1/20 0.38
KMT2A Q03164 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
KCNH2 Q12809 1/20 0.38
CES2 O00748 1/20 0.37
CES1 P23141 1/20 0.37
AGTR2 P50052 1/20 0.36
BCL2A1 Q16548 1/20 0.36
TSHR P16473 1/20 0.36
PTGIR P43119 1/20 0.36
PTGDR Q13258 1/20 0.36
APEX1 P27695 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12419483 0.78 ESR1 (0.44) ESR1ESR2PTPN1POLBKMT2A
SCHEMBL8245878 0.78 NPC1 (0.64) ESR1ESR2SMN1; SMN2POLBNPC1
SCHEMBL8242543 0.76 HTT (0.42) ESR1ESR2POLBNPC1RAB9A
SCHEMBL10698132 0.74 POLB (0.39) ESR1ESR2PTPN1SMN1; SMN2POLB
SCHEMBL2485185 0.74 SCN9A (0.52) ESR1ESR2KMT2AKCNH2TSHR
SCHEMBL10698137 0.74 SMN1; SMN2 (0.38) ESR1ESR2PTPN1SMN1; SMN2POLB
SCHEMBL5031160 0.74 ALDH1A1 (0.42) ESR1ESR2POLBNPC1RAB9A
SCHEMBL7813644 0.74 MEN1 (0.50) POLBNPC1RAB9AALDH1A1HTT
SCHEMBL12380247 0.73 ESR1 (0.41) ESR1ESR2ALDH1A1HTTKMT2A
SCHEMBL10364096 0.73 HDAC3 (0.44) ESR1ESR2ALDH1A1KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1831194-A1 HETEROCYCLIC MCHr1 ANTAGONISTS AND THEIR USE IN THERAPY AstraZeneca AB (SE) 2007-09-12 EP disclosed
WO-2006068594-A1 HETEROCYCLIC MCHr1 ANTAGONISTS AND THEIR USE IN THERAPY ASTRAZENECA AB (SE) 2006-06-29 WO disclosed